Healio5h
Ivarmacitinib curbs rheumatoid arthritis symptoms, improves function through 52 weeks
A once-daily dose of ivarmacitinib reduced disease activity and improved function among patients with rheumatoid arthritis ...
gastroenterologyadvisor12h
FDA Approves First Generic Liraglutide Once-Daily Injection
The US FDA approved the first generic referencing Victoza, a GLP-1 receptor agonist indicated to improve glycemic control.
The American Journal of Managed Care3d
Top GLP-1 Agonists Balance Weight Loss Efficacy, Safety
For this review, the authors searched for randomized controlled trials published in MEDLINE, Embase, and Cochrane CENTRAL ...
ALS News Today3d
Dosing begins in Phase 1 trial of potential ALS therapy RAG-17
A Phase 1 trial testing RAG-17, a potential ALS therapy for people carrying SOD1 mutations, has dosed its first participant.